An adviser's guide to Medicare open enrollment

An adviser's guide to Medicare open enrollment
Encourage clients to review their drug coverage and Advantage plans for 2019.
SEP 28, 2018

If you are younger than 65, you probably wonder what all the fuss is about as you're bombarded with television ads for Medicare Advantage and prescription drug plans each fall. As a financial adviser, you should view the annual Medicare open enrollment season, which begins Oct. 15 and runs through Dec. 7, as an opportunity to remind older clients to review their Medicare coverage to see if it still meets their needs. Each year, insurance companies can make changes to Medicare plans that can affect out-of-pocket costs for monthly premiums, deductibles and drug costs, and alter the makeup of healthcare providers or pharmacy networks. Changes in a client's health condition or prescriptions can mean their current Medicare or drug plan is no longer the best choice. Doing nothing can be a costly mistake. During Medicare open enrollment, individuals can move from original a la carte Medicare, which usually involves buying a separate Medicare Part D prescription drug plan and supplemental medigap policy, to an all-inclusive Medicare Advantage plan. In addition, they can switch from one Medicare Advantage plan to another or choose a different prescription drug plan. Competition will be particularly heated during this fall's open enrollment season as a result of upcoming changes in prescription drug plan costs for 2019 and the ability of Medicare Advantage plans to offer some new benefits, such as adult day care, home support and caregiver support services. Decisions about prescription drug plans for 2019 can have an enormous impact on a retiree's budget. A new analysis by The Senior Citizens League of the most frequently prescribed brand name drugs found there could be more than a $1,000 price difference among Medicare D prescription drug plans for the very same drug. For example, the diabetes drug Novolog Flexpen ranged from a low price of $37 through the Silver Script Choice plan and a high price of $2,012 through the Anthem Blue Medicare RX Premier plan, where the drug is not on the plan's list of covered drugs, known as a "formulary." "One look at the price comparison chart illustrates why Medicare beneficiaries need to check and compare drug plan prices during this fall's Medicare Open Enrollment," said Mary Johnson, a Medicare policy analyst for The Senior Citizens League who performed the price comparison using the Drug Plan Finder tool on the Medicare website. "To get the lowest costs and best plan, people need to compare plans based on all the drugs they take." Medicare's online Drug Plan Finder shows the combined cost of drugs and the premium, with the lowest-cost plan displayed first, Ms. Johnson explained. In addition, consumers should compare prices between in-network walk-in pharmacies and mail-order options, which can vary significantly. The National Council on Aging offers a free online guide to Medicare Open enrollment. NCOA also provides an online questionnaire to help Medicare beneficiaries compare plans and get free, detailed information from licensed benefits advisers. Free one-on-one counseling is also available nationwide through State Health Insurance Program counselors or by contacting the local Area Agency on Aging.

Medicare A, B, C and D's

Medicare comes in two flavors: original Medicare and Medicare Advantage. Original Medicare, used by most seniors, includes Part A hospital coverage and Part B coverage for outpatient services anywhere in the United States that accepts Medicare. Part A is free for most beneficiaries and the Part B standard premium of $134 per month is expected to remain the same in 2019, although an official announcement about 2019 premiums won't occur until later this year. High-income beneficiaries, defined as individuals with income of more than $85,000 and married couples with joint income of more than $170,000, pay more for Part B. Those enrolled in original Medicare usually add a Part D prescription drug plan, which involves a monthly premium as well as a surcharge for high-income beneficiaries. The average prescription drug plan premium is projected to be about $32.50 a month in 2019, down slightly from this year. However, premiums for specific plans vary from year to year. Medicare Advantage plans, sold by private insurers, include Medicare Part A and Part B, and most also include prescription drug coverage. Many Advantage plans offer additional benefits, such as vision and dental care, that are not covered by original Medicare. Medicare Advantage members pay the standard Part B premium and, in some cases, an additional monthly amount, but they do not need a separate Medigap or prescription drug policy. In exchange for generally lower monthly costs, all-inclusive Advantage plans usually restrict access to a network of doctors and medical facilities in a specific geographic area, and they may require prior approval to consult a specialist.

Latest News

How firms can support advisors during difficult market times
How firms can support advisors during difficult market times

For service-focused financial advisors who might take their well-being for granted, regular check-ins and active listening from the top can provide a powerful recharge.

Savant Wealth targets Silicon Valley with Parkworth acquisition
Savant Wealth targets Silicon Valley with Parkworth acquisition

With Parkworth Wealth Management and its Silicon Valley tech industry client base now onboard, Savant accelerates its vision of housing 10 to 12 specialty practices under its national RIA.

RIA moves: PE-backed Arax strengthens Midwestern presence with Summit Wealth Strategies
RIA moves: PE-backed Arax strengthens Midwestern presence with Summit Wealth Strategies

Meanwhile, $34 billion independent First Manhattan welcomed New Jersey-based Roanoke Asset Management, an RIA firm with more than 40 years of history.

Osaic sees more staff cuts
Osaic sees more staff cuts

Most notably, two chief compliance officers have also recently left the firm.

Advisor moves: Cetera lures 12-person team from LPL, Raymond James reels in Commonwealth duo
Advisor moves: Cetera lures 12-person team from LPL, Raymond James reels in Commonwealth duo

The latest team to join Cetera, led by a 29-year veteran professional, arrives with roughly $380 million in AUA from OSJ Private Advisor Group.

SPONSORED How advisors can build for high-net-worth complexity

Orion's Tom Wilson on delivering coordinated, high-touch service in a world where returns alone no longer set you apart.

SPONSORED RILAs bring stability, growth during volatile markets

Barely a decade old, registered index-linked annuities have quickly surged in popularity, thanks to their unique blend of protection and growth potential—an appealing option for investors looking to chart a steadier course through today's choppy market waters, says Myles Lambert, Brighthouse Financial.